TOKYO — Japanese drugmaker Takeda Pharmaceuticals will invest $30 billion in the U.S. over the next five years, CEO Christophe Weber said Thursday, with the money going toward both manufacturing facilities and research and development.
A string of major pharmaceutical makers around the world have come out with plans to invest in the U.S. after the Trump administration said that it was considering tariffs on drugs and medical products.
